Cleared Traditional

FUGO BLADE FOR PERIPHERAL IRIDOTOMY, MODEL M300 (K050933) - FDA 510(k) Clearance

Class II Ophthalmic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K050933 · Medisurg , Ltd. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2005
Decision
239d
Days
Class 2
Risk

K050933 is an FDA 510(k) clearance for the FUGO BLADE FOR PERIPHERAL IRIDOTOMY, MODEL M300. Classified as Apparatus, Cutting, Radiofrequency, Electrosurgical, Battery-powered (product code NCR), Class II - Special Controls.

Submitted by Medisurg , Ltd. (Norristown, US). The FDA issued a Cleared decision on December 9, 2005 after a review of 239 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4100 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Medisurg , Ltd. devices

Submission Details

510(k) Number K050933 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 14, 2005
Decision Date December 09, 2005
Days to Decision 239 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
129d slower than avg
Panel avg: 110d · This submission: 239d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NCR Apparatus, Cutting, Radiofrequency, Electrosurgical, Battery-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.